Guerbet Company
Guerbet
Guerbet is a human-scale company that aims to become a new global leader in medical imaging.
Pioneer in contrast media with 90 years' experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors.
The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostic (IRT) products, along with a range of injectors and related medical devices to improve patients' diagnosis, prognosis and quality of life.
More than 60,000 health professionals rely on Guerbet's contrast agents. Advancing in innovation solutions, the diagnosis of major diseases (cardiovascular diseases, cancers, diseases of the central nervous system) and interventional radiology while reconciling efficacy and cost containment, are at the heart of Guerbet's mission.
Since the acquisition of Mallinckrodt's "Contrast Media and Delivery Systems" activity, its total workforce is of 2,600 employees.
Achieve, Cooperate, Care and Innovate are the values that Guerbet's employees share and practice every day. Working at Guerbet means playing a unique part in the future of medical imaging.
Passionate about its business, the company strive day in, day out to combine performance, quality and sustainable development.
For more information about Guerbet, please go to www.guerbet.com and follow Guerbet on Twitter @GuerbetGroup / @GuerbetCareers.
